Clinical Trial Update: Erythropoietin and Early Iron Supplement and Retinopathy of Prematurity

View source ↗

Summary

Clinical trial update on the use of erythropoietin with early iron supplementation for retinopathy of prematurity; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinopathy of Prematurity

Drugs mentioned

• Erythropoietin (erythropoietin)
• Iron supplement

Snippet

Sponsor: Sheba Medical Center | Conditions: Retinopathy of Prematurity | Status: UNKNOWN